Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.

In humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FI...

Full description

Bibliographic Details
Main Authors: Hewitson, K, Liénard, B, McDonough, M, Clifton, I, Butler, D, Soares, A, Oldham, N, McNeill, L, Schofield, C
Format: Journal article
Language:English
Published: 2007
_version_ 1826258285691404288
author Hewitson, K
Liénard, B
McDonough, M
Clifton, I
Butler, D
Soares, A
Oldham, N
McNeill, L
Schofield, C
author_facet Hewitson, K
Liénard, B
McDonough, M
Clifton, I
Butler, D
Soares, A
Oldham, N
McNeill, L
Schofield, C
author_sort Hewitson, K
collection OXFORD
description In humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FIH), respectively). One consequence of hypoxia is the accumulation of tricarboxylic acid cycle intermediates (TCAIs). In vitro assays were used to assess non-2OG TCAIs as inhibitors of purified PHD2 and FIH. Under the assay conditions, no significant FIH inhibition was observed by the TCAIs or pyruvate, but fumarate, succinate, and isocitrate inhibited PHD2. Mass spectrometric analyses under nondenaturing conditions were used to investigate the binding of TCAIs to PHD2 and supported the solution studies. X-ray crystal structures of FIH in complex with Fe(II) and fumarate or succinate revealed similar binding modes for each in the 2OG co-substrate binding site. The in vitro results suggest that the cellular inhibition of PHD2, but probably not FIH, by fumarate and succinate may play a role in the Warburg effect providing that appropriate relative concentrations of the components are achieved under physiological conditions.
first_indexed 2024-03-06T18:31:34Z
format Journal article
id oxford-uuid:09d28232-edab-450f-a5ba-785662b0a990
institution University of Oxford
language English
last_indexed 2024-03-06T18:31:34Z
publishDate 2007
record_format dspace
spelling oxford-uuid:09d28232-edab-450f-a5ba-785662b0a9902022-03-26T09:20:27ZStructural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:09d28232-edab-450f-a5ba-785662b0a990EnglishSymplectic Elements at Oxford2007Hewitson, KLiénard, BMcDonough, MClifton, IButler, DSoares, AOldham, NMcNeill, LSchofield, CIn humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FIH), respectively). One consequence of hypoxia is the accumulation of tricarboxylic acid cycle intermediates (TCAIs). In vitro assays were used to assess non-2OG TCAIs as inhibitors of purified PHD2 and FIH. Under the assay conditions, no significant FIH inhibition was observed by the TCAIs or pyruvate, but fumarate, succinate, and isocitrate inhibited PHD2. Mass spectrometric analyses under nondenaturing conditions were used to investigate the binding of TCAIs to PHD2 and supported the solution studies. X-ray crystal structures of FIH in complex with Fe(II) and fumarate or succinate revealed similar binding modes for each in the 2OG co-substrate binding site. The in vitro results suggest that the cellular inhibition of PHD2, but probably not FIH, by fumarate and succinate may play a role in the Warburg effect providing that appropriate relative concentrations of the components are achieved under physiological conditions.
spellingShingle Hewitson, K
Liénard, B
McDonough, M
Clifton, I
Butler, D
Soares, A
Oldham, N
McNeill, L
Schofield, C
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title_full Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title_fullStr Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title_full_unstemmed Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title_short Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
title_sort structural and mechanistic studies on the inhibition of the hypoxia inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
work_keys_str_mv AT hewitsonk structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT lienardb structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT mcdonoughm structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT cliftoni structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT butlerd structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT soaresa structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT oldhamn structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT mcneilll structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates
AT schofieldc structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates